RRR Q2 Deep Dive: Property Investments Offset Margin Pressures Amid Construction Disruption
Casino resort and entertainment company Red Rock Resorts (NASDAQ:RRR) reported Q2 CY2026 results topping the market’s revenue expectations, but sales...
archivefinancial analysis
Douglas Dynamics (PLOW) Stock Trades Down, Here Is Why
What Happened? Shares of snow and ice equipment company Douglas Dynamics (NYSE:PLOW) fell 8% in the afternoon session after the...
ALHC Q2 Deep Dive: Investments in Clinical Innovation and Member Growth Drive Mixed Market Response
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 31.6% year...
MGIC Investment’s (NYSE:MTG) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Mortgage insurer MGIC Investment (NYSE:MTG) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 2.9% year on...
1 Momentum Stock to Target This Week and 2 Facing Challenges
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals...
CHWY Q4 Deep Dive: Margin Expansion and Strategic Investments Drive Positive Outlook
E-commerce pet food and supplies retailer Chewy (NYSE:CHWY) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.7%...
CAVA Q1 Deep Dive: Menu Innovation and Operational Investments Drive Strong Growth
Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 32.1% year...
ServiceNow and Snowflake Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after President Trump's state visit to Beijing lifted market...
HASI Q1 Deep Dive: Renewable Investment Growth and Capital Efficiency Propel Results
Climate investment firm HA Sustainable Infrastructure Capital (NYSE:HASI) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up...
MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins
Genetic testing company Myriad Genetics (NASDAQ:MYGN) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.3% year on...
